Lamb Weston (LW) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
8 Jul, 2026Executive summary
Q2 FY25 results missed expectations, with net sales down 8% to $1,601 million and a net loss of $36 million, driven by restructuring charges, higher manufacturing costs, and soft global demand.
Adjusted EBITDA fell 25% to $282 million, and adjusted net income dropped 55% to $95 million, reflecting weak restaurant traffic and increased competition.
A major restructuring plan was launched, including facility closures, production curtailments, and workforce reductions, targeting $55 million in FY25 cost savings and $85 million annualized in FY26.
Capital expenditures are shifting from growth to maintenance and modernization, with FY25 capex guidance reduced to $750 million.
Share repurchase authorization was increased to $750 million, with $82 million repurchased in H1 FY25 and $558 million remaining available.
Financial highlights
Q2 FY25 net sales declined 8% year-over-year to $1,600.9 million; first half net sales down 4% to $3,255.0 million.
Adjusted EBITDA for Q2 was $281.9 million, down $95 million year-over-year; first half Adjusted EBITDA was $571.8 million, down $217.9 million.
Net loss for Q2 was $36.1 million, compared to net income of $215.0 million in the prior year; first half net income was $91.3 million, down from $449.8 million.
Cash from operations for the first half was $429.3 million, down $25.9 million year-over-year; capital expenditures for H1 FY25 were $486.4 million.
Gross margin and operating income declined sharply due to higher input and production costs and lower volumes.
Outlook and guidance
FY25 net sales target reduced to $6.35–$6.45 billion (previously $6.6–$6.8 billion), implying a 1–2% sales decline versus FY24.
Adjusted EBITDA target lowered to $1.17–$1.21 billion from $1.38 billion; adjusted diluted EPS now $3.05–$3.20 (previously $4.15–$4.35).
Second half sales expected at $3.1–$3.2 billion, with adjusted EBITDA of $600–$640 million and margin of 19–20%.
Capital expenditures for FY25 targeted at $750 million, declining to $550 million in FY26.
Effective tax rate expected at 28%; GAAP net income target $330–$350 million.
Latest events from Lamb Weston
- Q4 sales rose 4% with cost savings, but margin pressures persist into FY26 guidance.LW
Q4 20258 Jul 2026 - Q4 profit and sales fell on soft demand and product withdrawal; FY25 outlook remains cautious.LW
Q4 20248 Jul 2026 - Operational improvements, disciplined capital use, and innovation drive growth amid global challenges.LW
21st Annual Global Farm to Market Conference13 May 2026 - Sales rose 3% as North America growth offset cost and international pressures, but net income fell sharply.LW
Q3 20261 Apr 2026 - Q3 FY25 sales up 4% with higher volume, cost savings, and reaffirmed guidance amid headwinds.LW
Q3 20254 Feb 2026 - Net income fell 46% as restructuring and cost actions target $55M in FY25 savings.LW
Q1 202519 Jan 2026 - Q2 2026 saw 8% volume growth, margin headwinds, and a 3% dividend increase.LW
Q2 202619 Dec 2025 - Board refresh, CEO transition, and pay-for-performance drive strategic and governance changes.LW
Proxy Filing1 Dec 2025 - Board recommends approval of all proposals, highlighting governance, pay, and ESG focus.LW
Proxy Filing1 Dec 2025